Thursday, September 13, 2018

CODA Therapeutics Raises $19M

South San Francisco-based CODA Biotherapeutics has raised $19M in a Series A funding, led by Versant Ventures and MPM Capital, with participation from Astellas Venture Management and Novartis, the company said this week. The new startup--incubated by Versant Ventures and MPM Capital-says it is developing gene therapy techniques, around what it calls a "chemogenetic platform" which it says aims to control the activity of neurons and other cells to treat diseases. More information »